

CHICAGO TRIBUNE: Duchenne muscular dystrophy drug could get OK for U.S. sales in 2016
The Chicago Tribune spoke to families and advocates seeking better treatment options for Duchenne muscular dystrophy as part of their coverage of Marathon Pharmaceuticals, a company working to earn U.S. approval for a Duchenne muscular dystrophy treatment. A Northbrook company said it has won fast-track status for approval of a drug that could become the first in the United States to treat Duchenne muscular dystrophy, a fatal muscle disease found most often in boys... U.S. Fo